NCT01888328View on ClinicalTrials.gov

Bioequivalence Study of Isotretinoin Capsules 40 mg Under Fed Condition

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

May 31, 2001

Primary Completion Date

May 31, 2001

Study Completion Date

June 30, 2001

Conditions
Healthy
Interventions
DRUG

Isotretinoin

Isotretinoin Capsules,40 mg

Trial Locations (1)

27514

AAI, Quadrangle Drive, Chapel Hill,

Sponsors
All Listed Sponsors
lead

Dr. Reddy's Laboratories Limited

INDUSTRY